Previous Page  15 / 27 Next Page
Information
Show Menu
Previous Page 15 / 27 Next Page
Page Background

allied

academies

Page 52

June 06-07, 2019 | London, UK

2

nd

International Conference on

Tissue Science and Molecular Biology,

Stem Cells & Separation Techniques

Joint Event

Biomedical Research (An International Journal of Medical Sciences) | ISSN: 0976-1683 Volume 30

Mesenchymal stem cells-based therapy for glaucoma through regeneration of the

trabecular meshwork

Christian Tebid Tebid

Centre de recherche Hôpital Maisonneuve-Rosemont (CRHMR), Canada

I

n open angle glaucoma, dysfunction of the trabecular

meshwork (TM) leads to elevated intraocular pressure

(IOP) and concomitant optic nerve damage. Consequently,

regeneration of the TM cells may represent an effective

therapeutic option formany cases of glaucoma.Wepreviously

demonstrated the regenerative effects of mesenchymal stem

cells conditioned media (MSC-CM) in tissue regeneration in

laser damaged TM. This process led to a decrease in IOP in a

ratmodel of glaucoma. Thismechanism is depended solely on

macrophage recruitment. In this study, we have investigated

the mechanism of MSC-CM educated macrophages on tissue

regeneration. To better understand the role of macrophages

in the TM regeneration process, rats were pretreated with

clodronate liposomes resulting ina reduction in thenumber of

macrophages within the damaged TM. This culminated in the

attenuation of the effect of MSC-CM on the IOP. In addition,

reintroduction of

in vitro

MSC-CM educated macrophages

into macrophage depleted eyes restored the healing effect.

Furthermore, to elucidate the mechanistic basis of MSC-CM

educatedmacrophages-mediateddecreaseinIOP,weinjected

the supernatant from MSC-CM educated macrophages into

glaucomatous eyes. Surprisingly, this resulted in a decrease in

the IOP, thus indicating that MSC-CM educated macrophages

mediate TM regeneration and a decrease in IOP through

paracrine factor secretion. In addition, we have identified one

factor which we call RPF1 (Regenerative paracrine factor 1)

produced by MSC-CM educated macrophages as a potent

mediator of this regenerative effect. This finding provides a

novel cellular therapeutic approach for glaucoma treatment.

e

:

chris_tebid@yahoo.co.uk

Biomed Res, Volume 30

ISSN: 0976-1683